Strategic Expansion CRYOGENE operates a large 75,000 square foot secure campus near the Texas Medical Center and is a leading U.S. biorepository. This points to capacity for scale, potential cross-sell of additional storage and distribution services, and integration with neighboring clinical research institutions and biotech startups seeking compliant biostorage.

Acquisition Legacy CRYOGENE was acquired by Cryoport in 2019 for $20M, indicating strategic alignment with a broader temperature-controlled logistics ecosystem. This history suggests opportunities to position value-added cold chain services, end-to-end solutions, and preferred-vendor status within Cryoport’s network for new or expanding clients.

Tech Enabled Utilizes advanced cryogenic systems and inventory-control software, with a tech stack including Google Cloud and analytics tools. This creates a foundation for offering enhanced data services, real-time inventory tracking, API integrations, and secure data sharing to research teams needing rigorous chain-of-custody.

Growth Fit Revenue is in the mid-range for specialized biotech storage providers and the company services local to national and international research centers. Growth opportunities exist in expanding storage tiers, distribution capabilities, and onboarding additional biobanking partners and CROs seeking compliant, scalable storage and logistics.

Market Positioning Operating adjacent to the Texas Medical Center with a focused biorepository niche positions CRYOGENE as a potential primary storage and distribution partner for mid to large biotech firms, academic labs, and industry players seeking secure, scalable, compliant biostorage backed by a proven ecosystem.